Once registered, you can:

  • - Read additional free articles each month
  • - Comment on articles and featured creative work
  • - Get our curated newsletters delivered to your inbox

By registering you agree to our privacy policy, terms & conditions and to receive occasional emails from Ad Age. You may unsubscribe at any time.

Are you a print subscriber? Activate your account.

Merck seeking shop for new-generation analgesic

Published on .

With a big new wave of prescription pain relievers expected next year, Merck & Co. looking for an ad agency to handle its as-yet unapproved brand, Vioxx. The drugs, called COX-2 inhibitors, have no stomach side effects. Those vying for the estimated $40 million to $50 million brand are all non-roster agencies: DDB Needham Worldwide, Grey Advertising, Messner Vetere Berger McNamee Schmetterer/Euro RSCG and Warwick Baker O'Neill, all New York.

Copyright August 1998, Crain Communications Inc.

Most Popular
In this article: